{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T05:12:52Z","timestamp":1792127572292,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.4065\/77.4.350","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:19:36Z","timestamp":1232759976000},"page":"350-354","source":"Crossref","is-referenced-by-count":56,"title":["Use of Intranasal Cromolyn Sodium for Allergic Rhinitis"],"prefix":"10.4065","volume":"77","author":[{"given":"Paul H.","family":"Ratner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley M.","family":"Fineman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli O.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Skoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/77.4.350_bib1","first-page":"1","article-title":"Current estimates from the National Health Interview Survey, 1996","volume":"200","author":"National Center for Health Statistics","year":"1999","journal-title":"Vital Health Stat 10"},{"issue":"pt 2","key":"10.4065\/77.4.350_bib2","doi-asserted-by":"crossref","first-page":"S808","DOI":"10.1016\/S0091-6749(97)80040-1","article-title":"Prevalence of allergic rhinitis in the United States","volume":"99","author":"Nathan","year":"1997","journal-title":"J Allergy Clin Immunol"},{"issue":"6, pt 1","key":"10.4065\/77.4.350_bib3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1542\/peds.94.6.895","article-title":"Epidemiology of physician-diagnosed allergic rhinitis in childhood","volume":"94","author":"Wright","year":"1994","journal-title":"Pediatrics"},{"issue":"5, pt 2","key":"10.4065\/77.4.350_bib4","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0091-6749(95)70213-X","article-title":"An overview of current pharmacotherapy in perennial rhinitis","volume":"95","author":"Meltzer","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.4065\/77.4.350_bib5","first-page":"373","article-title":"The cost of productivity losses associated with allergic rhinitis","volume":"6","author":"Crystal-Peters","year":"2000","journal-title":"Am J Manag Care"},{"issue":"5, pt 2","key":"10.4065\/77.4.350_bib6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1081-1206(10)63155-9","article-title":"Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology","volume":"81","author":"Dykewicz","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.4065\/77.4.350_bib7","first-page":"1","article-title":"Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997","volume":"143","author":"National Center for Health Statistics","year":"1999","journal-title":"Vital Health Stat 13"},{"issue":"3, pt 1","key":"10.4065\/77.4.350_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0091-6749(99)70320-9","article-title":"Allergic rhinobronchitis: the asthma-allergic rhinitis link","volume":"104","author":"Simons","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"1, pt 1","key":"10.4065\/77.4.350_bib9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0091-6749(99)70525-7","article-title":"Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges","volume":"103","author":"Yawn","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.4065\/77.4.350_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1081-1206(10)62612-9","article-title":"National guidelines needed to manage rhinitis and prevent complications","volume":"82","author":"Rachelefsky","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.4065\/77.4.350_bib11","author":"American Academy of Allergy, Asthma & Immunology"},{"key":"10.4065\/77.4.350_bib12","series-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","first-page":"667","article-title":"Drugs used in the treatment of asthma","author":"Serafin","year":"1996"},{"issue":"suppl","key":"10.4065\/77.4.350_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2222.1980.tb02162.x","article-title":"Review of clinical activity and mode of action of sodium cromoglycate","volume":"10","author":"Altounyan","year":"1980","journal-title":"Clin Allergy"},{"key":"10.4065\/77.4.350_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0091-6749(87)80183-5","article-title":"Disodium cromoglycate inhibits activation of human inflammatory cells in vitro","volume":"80","author":"Kay","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"10.4065\/77.4.350_bib15","first-page":"115","article-title":"Disodium cromoglycate (Intal)","volume":"5","author":"Cox","year":"1970","journal-title":"Adv Drug Res"},{"key":"10.4065\/77.4.350_bib16","series-title":"Disodium Cromoglycate in Allergic Airways Disease","first-page":"33","article-title":"Protective effect of disodium cromoglycate on nasal and bronchial reactions after allergen challenge","author":"Orie","year":"1970"},{"key":"10.4065\/77.4.350_bib17","first-page":"548","article-title":"Protective effect of disodium cromoglycate on the allergen provocation of the nasal mucosa","volume":"28","author":"Pelikan","year":"1970","journal-title":"Ann Allergy"},{"key":"10.4065\/77.4.350_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2222.1971.tb03018.x","article-title":"Disodium cromoglycate: laboratory studies and clinical trial in allergic rhinitis","volume":"1","author":"Taylor","year":"1971","journal-title":"Clin Allergy"},{"issue":"suppl 5, pt 2","key":"10.4065\/77.4.350_bib19","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/S0091-6749(96)70023-4","article-title":"ICln: a chloride channel paramount for cell volume regulation","volume":"98","author":"Gschwentner","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.4065\/77.4.350_bib20","first-page":"PL49","article-title":"Inhibition of rat peritoneal mast cell exocytosis by frusemide: a comparison with disodium cromoglycate","volume":"62","author":"Stenton","year":"1998","journal-title":"Life Sci"},{"issue":"suppl A","key":"10.4065\/77.4.350_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0954-6111(89)80247-1","article-title":"Reflections on the mechanism(s) of action of sodium cromoglycate (Intal) and the role of mast cells in asthma","volume":"83","author":"Holgate","year":"1989","journal-title":"Respir Med"},{"key":"10.4065\/77.4.350_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0091-6749(77)90156-7","article-title":"Cromolyn sodium nasal solution in the prophylactic treatment of pollen-induced seasonal allergic rhinitis","volume":"59","author":"Handelman","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"10.4065\/77.4.350_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0091-6749(77)90034-3","article-title":"Preseasonal IgE ragweed antibody level as a predictor of response to therapy of ragweed hay fever with intranasal cromolyn sodium solution","volume":"60","author":"Welsh","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"10.4065\/77.4.350_bib24","first-page":"131","article-title":"Double-blind controlled crossover trial of 4% intranasal sodium cromoglycate solution in patients with seasonal allergic rhinitis","volume":"49","author":"Chandra","year":"1982","journal-title":"Ann Allergy"},{"issue":"1, pt 2","key":"10.4065\/77.4.350_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0091-6749(76)90147-0","article-title":"Treatment of perennial allergic rhinitis with cromolyn sodium: double-blind study on 34 adult patients","volume":"58","author":"Cohan","year":"1976","journal-title":"J Allergy Clin Immunol"},{"key":"10.4065\/77.4.350_bib26","first-page":"240","article-title":"Sodium cromolyn nasal solution for the treatment of seasonal ragweed hay fever [abstract]","volume":"57","author":"Craig","year":"1976","journal-title":"J Allergy Clin Immunol"},{"key":"10.4065\/77.4.350_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2222.1977.tb01479.x","article-title":"Controlled trials with four per cent cromolyn spray in seasonal allergic rhinitis","volume":"7","author":"Posey","year":"1977","journal-title":"Clin Allergy"},{"issue":"4, pt 1","key":"10.4065\/77.4.350_bib28","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0091-6749(05)80212-X","article-title":"A multicenter trial of nedocromil sodium, 1% nasal solution, compared with cromolyn sodium and placebo in ragweed seasonal allergic rhinitis","volume":"86","author":"Schuller","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.4065\/77.4.350_bib29","first-page":"237","article-title":"Comparison of intranasal cromolyn sodium, 4%, and oral terfenadine for allergic rhinitis: symptoms, nasal cytology, nasal ciliary clearance, and rhinomanometry","volume":"66","author":"Orgel","year":"1991","journal-title":"Ann Allergy"},{"issue":"5, pt 2","key":"10.4065\/77.4.350_bib30","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0091-6749(88)90177-7","article-title":"Effects of topical nasal treatment on asthma symptoms","volume":"81","author":"Reed","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.4065\/77.4.350_bib31","first-page":"1165","article-title":"Superiority of beclomethasone over cromolyn in the self-treatment of seasonal allergic rhinitis [abstract]","volume":"18","author":"Kellerman","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.4065\/77.4.350_bib32","author":"Allergy, Asthma & Immunology Online"},{"key":"10.4065\/77.4.350_bib33","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1542\/peds.105.2.e23","article-title":"Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate","volume":"105","author":"Skoner","year":"2000","journal-title":"Pediatrics"},{"key":"10.4065\/77.4.350_bib34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0091-6749(95)70314-4","article-title":"Neuropsychiatric effects of medications for allergic diseases","volume":"95","author":"Bender","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.4065\/77.4.350_bib35","first-page":"70","article-title":"A step approach to the clinical management of allergic rhinitis: prescription and over-the-counter therapeutic reference summary","volume":"12","author":"Meltzer","year":"1999","journal-title":"Manag Care Interface"},{"key":"10.4065\/77.4.350_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(99)02542-8","article-title":"Risk of congenital malformations associated with treatment of asthma during early pregnancy [letter]","volume":"355","author":"Jadad","year":"2000","journal-title":"Lancet"},{"key":"10.4065\/77.4.350_bib37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0091-6749(97)70241-0","article-title":"The safety of asthma and allergy medications during pregnancy","volume":"100","author":"Schatz","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.4065\/77.4.350_bib38","series-title":"Seldane and Generic Terfenadine Withdrawn From Market","author":"Food and Drug Administration","year":"1998"},{"key":"10.4065\/77.4.350_bib39","first-page":"104","article-title":"Promotion of OTC products within a network-model HMO","volume":"9","author":"Gilderman","year":"1996","journal-title":"Med Interface"},{"key":"10.4065\/77.4.350_bib40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0025-6196(12)61882-5","article-title":"Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy","volume":"62","author":"Welsh","year":"1987","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/77.4.350_bib41","series-title":"Report of the Working Group on Asthma and Pregnancy: Management of Asthma During Pregnancy","author":"National Asthma Education Program","year":"1993"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611617886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611617886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T12:24:32Z","timestamp":1709987072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611617886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0025619611617886"],"URL":"https:\/\/doi.org\/10.4065\/77.4.350","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}